124 related articles for article (PubMed ID: 33006903)
41. Hedgehog Signaling and Truncated GLI1 in Cancer.
Doheny D; Manore SG; Wong GL; Lo HW
Cells; 2020 Sep; 9(9):. PubMed ID: 32957513
[TBL] [Abstract][Full Text] [Related]
42. Targeting GLI factors to inhibit the Hedgehog pathway.
Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L
Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120
[TBL] [Abstract][Full Text] [Related]
43. Gli Transcription Factors Mediate the Oncogenic Transformation of Prostate Basal Cells Induced by a Kras-Androgen Receptor Axis.
Wu M; Ingram L; Tolosa EJ; Vera RE; Li Q; Kim S; Ma Y; Spyropoulos DD; Beharry Z; Huang J; Fernandez-Zapico ME; Cai H
J Biol Chem; 2016 Dec; 291(49):25749-25760. PubMed ID: 27760825
[TBL] [Abstract][Full Text] [Related]
44. Silibinin induces apoptosis through inhibition of the mTOR-GLI1-BCL2 pathway in renal cell carcinoma.
Ma Z; Liu W; Zeng J; Zhou J; Guo P; Xie H; Yang Z; Zheng L; Xu S; Wang X; Chang LS; He D; Li L
Oncol Rep; 2015 Nov; 34(5):2461-8. PubMed ID: 26323996
[TBL] [Abstract][Full Text] [Related]
45. A patent review of RAF kinase inhibitors (2010-2018).
Man RJ; Zhang YL; Jiang AQ; Zhu HL
Expert Opin Ther Pat; 2019 Sep; 29(9):675-688. PubMed ID: 31370713
[No Abstract] [Full Text] [Related]
46. Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation.
Wang Y; Hsu JM; Kang Y; Wei Y; Lee PC; Chang SJ; Hsu YH; Hsu JL; Wang HL; Chang WC; Li CW; Liao HW; Chang SS; Xia W; Ko HW; Chou CK; Fleming JB; Wang H; Hwang RF; Chen Y; Qin J; Hung MC
Cancer Res; 2016 Dec; 76(23):7049-7058. PubMed ID: 27758883
[TBL] [Abstract][Full Text] [Related]
47. GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma.
Yang Z; Zhang C; Qi W; Cui Y; Xuan Y
Exp Cell Res; 2018 Dec; 373(1-2):145-154. PubMed ID: 30321514
[TBL] [Abstract][Full Text] [Related]
48. Fine-Tuning of GLI Activity through Arginine Methylation: Its Mechanisms and Function.
Abe Y; Tanaka N
Cells; 2020 Aug; 9(9):. PubMed ID: 32859041
[TBL] [Abstract][Full Text] [Related]
49. A genome scale RNAi screen identifies GLI1 as a novel gene regulating vorinostat sensitivity.
Falkenberg KJ; Newbold A; Gould CM; Luu J; Trapani JA; Matthews GM; Simpson KJ; Johnstone RW
Cell Death Differ; 2016 Jul; 23(7):1209-18. PubMed ID: 26868908
[TBL] [Abstract][Full Text] [Related]
50. WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function.
Pandolfi S; Montagnani V; Penachioni JY; Vinci MC; Olivito B; Borgognoni L; Stecca B
Oncogene; 2013 Oct; 32(40):4737-47. PubMed ID: 23146903
[TBL] [Abstract][Full Text] [Related]
51. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
[TBL] [Abstract][Full Text] [Related]
52. Suppression of GLI sensitizes medulloblastoma cells to mitochondria-mediated apoptosis.
Lin Z; Li S; Sheng H; Cai M; Ma LY; Hu L; Xu S; Yu LS; Zhang N
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2469-2478. PubMed ID: 27601167
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
Lauth M; Bergström A; Shimokawa T; Toftgård R
Proc Natl Acad Sci U S A; 2007 May; 104(20):8455-60. PubMed ID: 17494766
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets?
Ruiz i Altaba A
Cancer Cell; 2008 Oct; 14(4):281-3. PubMed ID: 18835029
[TBL] [Abstract][Full Text] [Related]
55. Discovery of Hedgehog Antagonists for Cancer Therapy.
Khatra H; Bose C; Sinha S
Curr Med Chem; 2017; 24(19):2033-2058. PubMed ID: 28302010
[TBL] [Abstract][Full Text] [Related]
56. Targeting GLI1 Suppresses Cell Growth and Enhances Chemosensitivity in CD34+ Enriched Acute Myeloid Leukemia Progenitor Cells.
Long B; Wang LX; Zheng FM; Lai SP; Xu DR; Hu Y; Lin DJ; Zhang XZ; Dong L; Long ZJ; Tong XZ; Liu Q
Cell Physiol Biochem; 2016; 38(4):1288-302. PubMed ID: 27008269
[TBL] [Abstract][Full Text] [Related]
57. RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma.
Akula SM; Abrams SL; Steelman LS; Emma MR; Augello G; Cusimano A; Azzolina A; Montalto G; Cervello M; McCubrey JA
Expert Opin Ther Targets; 2019 Nov; 23(11):915-929. PubMed ID: 31657972
[No Abstract] [Full Text] [Related]
58. Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy.
Pandolfi S; Stecca B
Expert Rev Mol Med; 2015 Feb; 17():e5. PubMed ID: 25660620
[TBL] [Abstract][Full Text] [Related]
59. Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitors.
Dagklis A; Demeyer S; De Bie J; Radaelli E; Pauwels D; Degryse S; Gielen O; Vicente C; Vandepoel R; Geerdens E; Uyttebroeck A; Boeckx N; de Bock CE; Cools J
Blood; 2016 Dec; 128(23):2642-2654. PubMed ID: 27694322
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of Gli leads to antitumor growth and enhancement of cisplatin-induced cytotoxicity in large cell neuroendocrine carcinoma of the lung.
Ishiwata T; Iwasawa S; Ebata T; Fan M; Tada Y; Tatsumi K; Takiguchi Y
Oncol Rep; 2018 Mar; 39(3):1148-1154. PubMed ID: 29328464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]